Items related to Streptokinase-A novel clot buster: Studies on screening,...
Streptokinase-A novel clot buster: Studies on screening, strain development, production and optimization of streptokinase from β-hemolytic streptococci - Softcover
The leading cause of death in the world is coronary heart diseases. According to World Health Organisation (WHO) cardiovascular disease caused over 18 million deaths in the world in 2005. Of these deaths, 8 million (44%) occurred in people under 60 years of age. In the recent years, of the several thrombolytic agents used clinically, streptokinase is prone of the most-often employed, particularly of its lower cost when coded to others. This book deals with streptokinase as a clinically important and cost-effective plasminogen activator. Streptokinase is a non-proteolytic extracellular protein produced by Streptococcus species. It is the best, least expensive, efficient, highly potent plasminogen activator of fibrinolysis and routinely applied in clinical medicine for thrombolytic therapy for the treatment of diverse circulatory disorders. Presently there is about 80- 90% of demand for streptokinase. As per market research 2011 report, Asia, Europe and North America are the leading countries worldwide in manufacturing and supplying streptokinase. This book provides more information about β hemolytic Streptococci and the strain improvement methods to enhance streptokinase production.
"synopsis" may belong to another edition of this title.
About the Author:
Dr.C.Subathra Devi and Dr.V.Mohanasrinivasan are currently working as Assistant Professor Senior at VIT University, Vellore, Tamil Nadu, India. Both of them are expertise in industrial enzymes especially on clot buster enzymes like streptokinase, staphylokinase and nattokinase which is used clincally as an intravenous thromobolytic agents.
"About this title" may belong to another edition of this title.
- PublisherLAP LAMBERT Academic Publishing
- Publication date2012
- ISBN 10 3659178683
- ISBN 13 9783659178689
- BindingPaperback
- Number of pages64
Buy New
Learn more about this copy
US$ 50.69
Shipping:
US$ 3.99
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
Streptokinase-A novel clot buster: Studies on screening, strain development, production and optimization of streptokinase from ?-hemolytic streptococci
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020268680
Buy New
US$ 50.69
Convert currency
Stock Image
Streptokinase-A novel clot buster
Published by
LAP Lambert Academic Publishing
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783659178689_lsuk
Buy New
US$ 56.50
Convert currency
Stock Image
Streptokinase-A novel clot buster
Published by
LAP Lambert Academic Publishing 2012-07
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
PF
Quantity: 10
Seller:
Rating
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783659178689
Buy New
US$ 52.10
Convert currency
Stock Image
StreptokinaseA novel clot buster Studies on screening, strain development, production and optimization of streptokinase from hemolytic streptococci
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659178689
Buy New
US$ 73.28
Convert currency
Seller Image
Streptokinase-A novel clot buster
Published by
LAP Lambert Academic Publishing
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The leading cause of death in the world is coronary heart diseases. According to World Health Organisation (WHO) cardiovascular disease caused over 18 million deaths in the world in 2005. Of these deaths, 8 million (44%) occurred in people under 60 years of age. In the recent years, of the several thrombolytic agents used clinically, streptokinase is prone of the most-often employed, particularly of its lower cost when coded to others. This book deals with streptokinase as a clinically important and cost-effective plasminogen activator. Streptokinase is a non-proteolytic extracellular protein produced by Streptococcus species. It is the best, least expensive, efficient, highly potent plasminogen activator of fibrinolysis and routinely applied in clinical medicine for thrombolytic therapy for the treatment of diverse circulatory disorders. Presently there is about 80- 90% of demand for streptokinase. As per market research 2011 report, Asia, Europe and North America are the leading countries worldwide in manufacturing and supplying streptokinase. This book provides more information about hemolytic Streptococci and the strain improvement methods to enhance streptokinase production. 64 pp. Englisch. Seller Inventory # 9783659178689
Buy New
US$ 54.00
Convert currency
Stock Image
StreptokinaseA novel clot buster Studies on screening, strain development, production and optimization of streptokinase from hemolytic streptococci
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659178689
Buy New
US$ 58.25
Convert currency
Seller Image
Streptokinase-A novel clot buster : Studies on screening, strain development, production and optimization of streptokinase from -hemolytic streptococci
Published by
LAP Lambert Academic Publishing
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The leading cause of death in the world is coronary heart diseases. According to World Health Organisation (WHO) cardiovascular disease caused over 18 million deaths in the world in 2005. Of these deaths, 8 million (44%) occurred in people under 60 years of age. In the recent years, of the several thrombolytic agents used clinically, streptokinase is prone of the most-often employed, particularly of its lower cost when coded to others. This book deals with streptokinase as a clinically important and cost-effective plasminogen activator. Streptokinase is a non-proteolytic extracellular protein produced by Streptococcus species. It is the best, least expensive, efficient, highly potent plasminogen activator of fibrinolysis and routinely applied in clinical medicine for thrombolytic therapy for the treatment of diverse circulatory disorders. Presently there is about 80- 90% of demand for streptokinase. As per market research 2011 report, Asia, Europe and North America are the leading countries worldwide in manufacturing and supplying streptokinase. This book provides more information about hemolytic Streptococci and the strain improvement methods to enhance streptokinase production. Seller Inventory # 9783659178689
Buy New
US$ 55.56
Convert currency
Seller Image
Streptokinase-A novel clot buster
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3659178683
ISBN 13: 9783659178689
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: C. Subathra DeviDr.C.Subathra Devi and Dr.V.Mohanasrinivasan are currently working as Assistant Professor Senior at VIT University, Vellore, Tamil Nadu, India. Both of them are expertise in industrial enzymes especially on clot buste. Seller Inventory # 5137354
Buy New
US$ 45.92
Convert currency